Infectious Disease Testing Market By Type Of Disease 2020 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Infectious Disease Testing Market
Infectious Disease Testing Market: By Type Of Disease (AIDS, Influenza, Rabies & Others); By Technique (PCR, DNA, Hybridization); By Industry (Hospitals, Blood Banks, Laboratories, Nursing Homes, Others) & Geography -Forecast (2016-2021)
Report Code : HCR 0085
Updated Date: 02 January, 2016  

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Customization Options
Infectious diseases are illnesses caused by infectious agents such as bacteria, viruses, fungi and parasites. The infectious diseases are mostly communicable and are also transmitted by bites from insects or animals, or by exposure to organisms in the environment. Other infectious diseases can affect organisms that ingest contaminated food or water. The impacts of these diseases are immense and can be felt across the world. Among the almost infinite varieties of microorganisms, relatively few are responsible for causing disease in otherwise healthy individuals. These disease causing microorganisms are known as pathogens.

Infectious disease results from the interaction between those few pathogens and the defenses of the hosts they infect. The form and severity of the diseases resulting from any pathogen depends upon the ability of that pathogen to damage the host as well as the immunity of the host to resist the pathogen.
The development of diagnostics of infectious diseases has resulted from advances in the field of chemistry, immunology, molecular biology, engineering, automation, and nucleic acid amplification. It is now possible to determine the specific etiology of a patient’s infectious disease in the hospital, clinic, office, or even a patient’s home.

The global market for infectious disease testing was estimated to be $XX billion in 2015 and is estimated to grow at a CAGR of XX% to reach $XX billion by 2021. The factors effecting the growth of infectious diseases is contaminated ground water, faulty water purification, changing in rendering process etc., the infectious diseases forecast to have the highest growth of X% during the forecast period 2016-2021. Oil & gas, Hospitals and Laboratories are the major end-users for infectious disease testing.

Infectious Disease Testing Market

On the basis of region, the Infectious disease testing market is segmented into North America, Europe, Asia-Pacific, and the Rest of World (RoW). In 2015, North America accounted for the largest share of the Infectious disease testing market, followed by Europe. Both markets are estimated to register single-digit growth rates over the next five years. However, Asia-Pacific is expected to register the highest growth rate during the forecast period, owing to the high prevalence of infectious diseases, and huge investment opportunities due to increase in healthcare expenditure.

The major players in the Infectious Disease Testing Market include:
  • Affymetrix, Inc.
  • Chembio Diagnostic Systems
  • Gene Express
  • Immunoassays
  • Thermo Fisher Scientific, Inc. 
1. Infectious Disease Testing Market Overview
2. Executive Summary
3. Infectious Disease Testing Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Infectious Disease Testing Market Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
   4.3. Attractiveness of the Infectious Disease Testing Market
      4.3.1. Power of Suppliers
      4.3.2. Threats From New Entrants
      4.3.3. Power of Buyer
      4.3.4. Threat From Substitute Product
      4.3.5. Degree of Competition
5. Infectious Disease Testing Market-Strategic Analysis
   5.1. Infectious Disease Testing - Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunity Analysis
   5.4. Product Life Cycle
   5.5. Suppliers and Distributors
6. Infectious Disease Testing Market -By Type Of Disease
   6.1. Introduction
   6.2. Influenza
   6.3. Hepatitis
   6.4. AIDS
   6.5. Tuberculosis
   6.6. Rabies
   6.7. Cholera
   6.8. Dengue
   6.9. Others
7. Infectious Disease Testing Market -By Testing Technique
   7.1. Introduction
   7.2. Immuno diagnostics
   7.3. Biochemical Characterization
   7.4. Microscopy
   7.5. Polymerase Chain Reaction(PCR)
   7.6. Deoxyribonucleic Acid (DNA) Sequencing
   7.7. Microarrays
   7.8. Hybridization
   7.9. Others
8. Infectious Disease Testing Market-By Industry
   8.1. Laboratories
   8.2. Nursing Homes
   8.3. Blood Banks
   8.4. Hospitals
   8.5. Research Labs
   8.6. Others
9. Infectious Disease Testing Market-By Geography
   9.1. North America
      9.1.1. U.S.
      9.1.2. Canada
      9.1.3. Mexico
   9.2. Europe
      9.2.1. U.K.
      9.2.2. Germany
      9.2.3. Italy
      9.2.4. Rest of Europe
   9.3. Asia-Pacific
      9.3.1. China
      9.3.2. South Korea
      9.3.3. Australia & New Zealand
      9.3.4. Japan
      9.3.5. India
      9.3.6. Rest of APAC
   9.4. Rest of The World (ROW)
      9.4.1. Middle East
      9.4.2. Africa
      9.4.3. South America
10. Infectious Disease Testing Market-Entropy
   10.1. New Product Developments
   10.2. Product Launchers, JVs, Mergers and Acquisitions
11. Company Profiles
   11.1. Abbott Laboratories
   11.2. Affymetrix, Inc.
   11.3. Biotheranostics
   11.4. Cepheid
   11.5. Chembio Diagnostic Systems
   11.6. DiaSorin
   11.7. Entrogen, Inc
   11.8. Ferrer Incode
   11.9. Gene Express
   11.10. Grifols
   11.11. Hologic
   11.12. Immunoassays
   11.13. Johnson and Johnson
   11.14. Life Technologies Corporation
   11.15. Luminex Corporation
   11.16. Sirs-Lab
   11.17. Thermo Fisher Scientific, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
   12.1. List of Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Expert Insights 
   12.5. Disclaimer
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports